WO2013093514A3 - Vaccines - peptides - Google Patents

Vaccines - peptides Download PDF

Info

Publication number
WO2013093514A3
WO2013093514A3 PCT/GB2012/053255 GB2012053255W WO2013093514A3 WO 2013093514 A3 WO2013093514 A3 WO 2013093514A3 GB 2012053255 W GB2012053255 W GB 2012053255W WO 2013093514 A3 WO2013093514 A3 WO 2013093514A3
Authority
WO
WIPO (PCT)
Prior art keywords
peptides
influenza
vaccines
derived
cell immunity
Prior art date
Application number
PCT/GB2012/053255
Other languages
French (fr)
Other versions
WO2013093514A2 (en
Inventor
Robert Lambkin-Williams
John Sidney Oxford
Thomas Wilkinson
Chris Li
Anthony Gilbert
Andrew Mcmichael
Xiao-Ning Xu
Original Assignee
Retroscreen Virology Ltd
University Of Southampton
The Chancellor, Masters And Scholars Of The University Of Oxford
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1122299.9A external-priority patent/GB201122299D0/en
Application filed by Retroscreen Virology Ltd, University Of Southampton, The Chancellor, Masters And Scholars Of The University Of Oxford filed Critical Retroscreen Virology Ltd
Publication of WO2013093514A2 publication Critical patent/WO2013093514A2/en
Publication of WO2013093514A3 publication Critical patent/WO2013093514A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/572—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 cytotoxic response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Abstract

The present invention provides influenza peptide antigens which may be used to induce T cell responses, and not only to the particular influenza strain from which peptide antigen was derived, but also to peptides derived from other influenza strains. These peptides, and vaccines comprising these peptides, are useful in inducing T cell immunity to influenza and advantageously the T cell immunity is to more than one type of influenza.
PCT/GB2012/053255 2011-12-23 2012-12-21 Vaccines - peptides WO2013093514A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201113336658A 2011-12-23 2011-12-23
US13/336,658 2011-12-23
GBGB1122299.9A GB201122299D0 (en) 2011-12-23 2011-12-23 Vaccines-peptides
GB1122299.9 2011-12-23

Publications (2)

Publication Number Publication Date
WO2013093514A2 WO2013093514A2 (en) 2013-06-27
WO2013093514A3 true WO2013093514A3 (en) 2013-08-15

Family

ID=47561656

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2012/053255 WO2013093514A2 (en) 2011-12-23 2012-12-21 Vaccines - peptides

Country Status (1)

Country Link
WO (1) WO2013093514A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7146926B2 (en) 2017-09-29 2022-10-04 ヴァクディアグン バイオテクノロジー カンパニー リミテッド Fusion peptide of CD4 helper T cell epitope and its vaccine

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015033137A1 (en) 2013-09-04 2015-03-12 Imperial Innovations Limited Biological methods and materials for use therein

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007091030A2 (en) * 2006-02-07 2007-08-16 Peptcell Limited Peptide sequences and compositions
WO2008039267A2 (en) * 2006-07-21 2008-04-03 Pharmexa Inc. Inducing cellular immune responses to influenza virus using peptide and nucleic acid compositions
WO2009027688A1 (en) * 2007-08-31 2009-03-05 Immune Targeting Systems (Its) Ltd Influenza antigen delivery vectors and constructs
US20100285050A1 (en) * 2007-10-05 2010-11-11 Isis Innovation Limited Compositions and Methods

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007091030A2 (en) * 2006-02-07 2007-08-16 Peptcell Limited Peptide sequences and compositions
WO2008039267A2 (en) * 2006-07-21 2008-04-03 Pharmexa Inc. Inducing cellular immune responses to influenza virus using peptide and nucleic acid compositions
WO2009027688A1 (en) * 2007-08-31 2009-03-05 Immune Targeting Systems (Its) Ltd Influenza antigen delivery vectors and constructs
US20100285050A1 (en) * 2007-10-05 2010-11-11 Isis Innovation Limited Compositions and Methods

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7146926B2 (en) 2017-09-29 2022-10-04 ヴァクディアグン バイオテクノロジー カンパニー リミテッド Fusion peptide of CD4 helper T cell epitope and its vaccine

Also Published As

Publication number Publication date
WO2013093514A2 (en) 2013-06-27

Similar Documents

Publication Publication Date Title
PH12014502438A1 (en) Prostate-associated antigens and vaccine-based immunotherapy regimens
MX2015008847A (en) Influenza virus immunogenic compositions and uses thereof.
WO2013106834A3 (en) Immunogenic wt-1 peptides and methods of use thereof
WO2011109833A3 (en) Induced dendritic cell compositions and uses thereof
MX352338B (en) Neutralizing anti-influenza a virus antibodies and uses thereof.
WO2015142671A3 (en) Influenza virus vectors and uses therefor
WO2013054199A3 (en) Cmv antigens and uses thereof
WO2011103453A3 (en) Vaccines for use in the prophylaxis and treatment of influenza virus disease
WO2014113490A3 (en) Immunogenic wt-1 peptides and methods of use thereof
WO2013084071A3 (en) Clostridium difficile toxin-based vaccine
MX2013007918A (en) Monomeric and multimeric immunogenic peptides.
IN2014DN10288A (en)
TR201905619T4 (en) Peptide carrier fusion proteins as allergy vaccines.
MX344103B (en) Newcastle disease virus vectored herpesvirus vaccines.
WO2013188673A3 (en) Reassortant btv and ahsv vaccines
MX2016012840A (en) Improved modular antigen transportation molecules and uses therof.
MY191217A (en) Group a streptococcus vaccine
MX2014001626A (en) Vacuum -assisted preservation of biological products, in particular of vaccines.
WO2014151834A3 (en) Methods and compositions relating to anti-ccr7 antigen binding proteins
WO2014043220A3 (en) Hiv-1 envelope proteins and fragments thereof that possess epitopes recognized by broadly neutralizing antibodies
WO2011100508A3 (en) Methods and compositions related to glycoprotein-immunoglobulin fusions
MX2019007924A (en) Influenza vaccines.
WO2013093514A3 (en) Vaccines - peptides
MX368484B (en) Vaccination by means of recombinant yeast by producing a protective humoral immune response against defined antigens.
WO2013173256A3 (en) New and improved influenza vaccines

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12816094

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 12816094

Country of ref document: EP

Kind code of ref document: A2